Below we explain our risk-sharing model for research proposals:
- Risk sharing concept. The concept behind risk-sharing is that when we come in as a subcontractor in your proposal, we will be sharing the risk of the proposal not being funded. In other words, if the funding agency awards the project, SporeData is paid to deliver the Data Science services outlined in the proposal. If the agency does not award the project, then you have no costs, and we will usually attempt to reshape the proposal and resubmit.
- Selection criteria. Our criteria for selecting in which proposals we will or not participate are flexible, but we usually look at a few parameters. First, we need to ensure that we have the internal resources to dedicate to that specific proposal. A proposal is attractive when principal investigators can bring in substantial content expertise demonstrated through previous publications. Other factors include an extensive network involving other specialists, a commitment to complete a very high-quality submission, and the persistence to revise the proposal if the initial attempt was not successful.
- Agile iteration. Our workflow for proposal preparation involves weekly drafts for feedback. This continuous delivery protocol ensures alignment in the expectations of all team members. Also, following weekly deliverables allows us to complete an initial draft usually within weeks from the deadline, allowing the team with plenty of time to deliver a high-quality document.
- Subcontracting. SporeData’s costs are established upfront in a fully transparent process, usually by the time we discuss the one-page project summary. Note that the model used in risk sharing is different from our other business model focused on person-hours for Data Science support.
- Principal investigator’s responsibilities. The Principal Investigators’ teams are in charge of writing the Background and Innovation sections, reviewing and providing feedback on our drafts of the Approach section, preparing the proposal administrative sections, and, finally, submitting the proposal through their institutions. SporeData will review the other sections and will also provide templates for letters of support.
- Our intellectual property policy. We do not claim ownership on any intellectual property related to clinical or policy findings generated during any of our projects. We made this decision to facilitate the interaction with academic centers, governments, and companies, which would otherwise lead our projects into protracted cycles.